Reboxetine
未知生产厂商
Reboxetine is a drug used for the acute treatment of major depression and for maintenance therapy of depression.
Reboxetine is a drug used for the acute treatment of major depression and for maintenance therapy of depression.
Reboxetine is a selective inhibitor of noradrenaline reuptake. It inhibits noradrenaline reuptake in vitro to a similar extent to the tricyclic antidepressant desmethylimipramine. Reboxetine does not affect dopamine or serotonin reuptake and it has low in vivo and in vitro affinity for adrenergic, cholinergic, histaminergic, dopaminergic and serotonergic receptors.
For the treatment of clinical depression.
共 1 项相关疾病
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。